Skip to main content

Ad5-yCD/mutTKSR39rep-ADP adenovirus

Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma

  • RegistryNCT05686798
  • PhasePhase 1
  • StatusRecruiting
  • ConditionMalignant Glioma of Brain
  • SponsorHenry Ford Health System
How Ad5-yCD/mutTKSR39rep-ADP adenovirus worksNCT056867981 min

What the film says

Read the transcript

When glioblastoma grows back, surgeons can operate again, but cells remain in the cavity wall, and those regrow.

The idea: at the end of that second surgery, seed the cavity wall with a virus that turns tumor cells into their own chemotherapy factories.

It is a common-cold adenovirus, rebuilt to multiply only in cancer cells, carrying two extra genes. Each converts a harmless pill, an antifungal and an antiviral, into a drug that kills dividing cells where the virus is. Radiation follows; both drugs make tumor cells more sensitive to it.

Henry Ford Health in Detroit tested this virus in prostate cancer for years. This trial, with Tobias Walbert, brings it to the brain, asking what dose is safe. Public record; not medical advice.

Sources behind this film

Show 1 more sources

The drug

What is being tested.

Ad5-yCD/mutTKSR39rep-ADP adenovirus will be injected intratumoral

Detailed study description: Patients with recurrent glioblastoma (GBM) or progressive high grade astrocytoma who are scheduled to undergo repeat surgery are eligible. After the removal of as much tumor tissue as possible, a modified oncolytic adenovirus is injected into the wall of the resection cavity and any residual tumor tissue. The goal of this study is to determine the maximum tolerated dose (MTD) of the injected adenovirus.

This treatment is combined with a combination of oral 5-fluorocytosine (5-FC) and valganciclovir (vGCV) prodrug therapy. Following the surgery, patients will be treated with fractionated radiosurgery (fSRS). Patients will be monitored for 30 days before they start on next line anti-cancer therapy.

The study

How the trial runs.

The primary goal of this Phase I study is to determine the maximum tolerated dose of oncolytic adenovirus mediated double suicide-gene therapy in combination with fractionated stereotactic radiosurgery in patients with recurrent high-grade astrocytoma undergoing resection.

Live record on ClinicalTrials.gov →

Eligibility

Who the study is looking for.

  • Subjects with radiologic evidence of intracranial recurrence or progression of a previously diagnosed high-grade astrocytoma.
  • To be eligible for this trial, the subjects must have:
  • Histologically documented glioblastomas or anaplastic astrocytoma prior to the debulking surgery that is suspicious to have progressed on imaging. An interval of at least 3 months must have elapsed since the completion of the most recent course of radiation while at least 4 weeks must have elapsed since the completion of a non-nitrosourea containing chemotherapy regimen and at least 6 weeks since the completion of a nitrosourea containing chemotherapy regimen.
  • Patients must be ≥ 18 years of age, able to provide informed consent and express a willingness to meet all the expected requirements of the protocol for the duration of the study.
  • Must have recovered from toxicity (grade 2 or less) of prior therapy.
  • Eligible for partial or total resection of the recurrent tumor

Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.

For you, or someone you love

Whether or not this trial is the one, bring AI into your corner.

A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.

Start your 7-day free trial

Then $9 a month. Cancel anytime.

  • Every record in one place

    Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.

  • Read in plain words

    Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.

  • Ready for every appointment

    Ask about your own file, and walk in with questions for your oncologist or the trial team.

  • Your people, in the loop

    Share one profile with the family helping you, and with your doctors.

Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.

How these trials work: what Phase 1 actually is · common questions Not clinical evidence.